Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.64
Delayed Data
As of Feb 12
 -0.01 / -0.61%
Today’s Change
1.39
Today|||52-Week Range
9.37
-4.65%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Booth Mark D
Chief Commercial Officer
Sale2/26/201550,000$5.68$284.0K-72.06%
Booth Mark D
Chief Commercial Officer
Buy2/26/201550,000$1.66$83.0K-72.06%
Cannell Thomas R
EVP & Chief Commercial Officer
Gift11/30/20155,091$2.03$10.3K-31.38%
Klassen Preston S
Executive Vice President-Global Development
Gift11/30/20154,170$2.03$8.5K-31.38%
Klassen Preston S
Executive Vice President-Global Development
Gift5/30/20151,860$4.17$7.8K-66.60%
Narachi Michael A
President & Chief Executive Officer
Gift11/30/20151,761$2.03$3.6K-31.38%
Narachi Michael A
President & Chief Executive Officer
Gift5/29/2015721$4.17$3.0K-66.53%